Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1598296477
Since 2017
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 Route 112 Ste 101
Port Jefferson Station, NY, 11776
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
189,498 services
Medicare patients, 2024
2,068
Average age 76
Drug cost, 2024
$6.5M
1,258 prescriptions
Company payments, 2025
$79.61
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jin Guo was code J1439 (injection, ferric carboxymaltose, 1 mg), 75,000 times for 77 patients. In total Jin Guo billed 189,498 services in 277 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 75,000 | 77 | $0.87 | $65K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 11,700 | 19 | $2.33 | $27K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,000 | 20 | $44.73 | $447K |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,601 | 35 | $0.18 | $1,545 |
| J0897 Injection, denosumab, 1 mg | Office | 4,680 | 33 | $20.54 | $96K |
| 88185 Surgical Pathology Examination | Office | 4,592 | 165 | $21.85 | $100K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,050 | 16 | $37.45 | $114K |
| 85025 Blood Count | Office | 2,645 | 1,259 | $7.59 | $20K |
| 36415 Venipuncture Blood Collection | Office | 2,635 | 1,258 | $8.65 | $23K |
| 80053 Clinical Chemistry | Office | 2,033 | 1,086 | $10.29 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,008 | 105 | $0.09 | $179 |
| 99214 Office E&M - Established | Office | 1,380 | 675 | $106.50 | $147K |
| J0131 Injection, acetaminophen, not otherwise specified,10 mg | Office | 1,200 | 12 | $0.04 | $46.77 |
| 82784 Immunoassay | Office | 1,032 | 234 | $9.09 | $9,378 |
| 82728 Clinical Chemistry | Office | 1,004 | 609 | $13.28 | $13K |
By year: 2023 $404K for 26,251 services; 2024 $2.5M for 189,498 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 4,592 | 165 | $21.85 | $100K |
| 85025 Blood Count | 2,645 | 1,259 | $7.59 | $20K |
| 36415 Venipuncture Blood Collection | 2,635 | 1,258 | $8.65 | $23K |
| 80053 Clinical Chemistry | 2,033 | 1,086 | $10.29 | $21K |
| 82784 Immunoassay | 1,032 | 234 | $9.09 | $9,378 |
| 82728 Clinical Chemistry | 1,004 | 609 | $13.28 | $13K |
| 84100 Clinical Chemistry | 995 | 641 | $4.61 | $4,586 |
| 83540 Clinical Chemistry | 976 | 594 | $6.30 | $6,146 |
| 83550 Clinical Chemistry | 953 | 583 | $8.50 | $8,098 |
| 83735 Clinical Chemistry | 949 | 605 | $6.52 | $6,183 |
Medicare prescription drug claims, 2024
In 2024, the drug Jin Guo prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 190 prescriptions and refills. In total Jin Guo wrote 1,258 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 190 | 190 | 39 | $681K |
| Eliquis Apixaban | 87 | 129 | 21 | $74K |
| Hydroxyurea Generic | 72 | 100 | 14 | $1,296 |
| Imbruvica Ibrutinib | 52 | 52 | Under 11 | $801K |
| Prednisone Generic | 50 | 50 | Under 11 | $282 |
| Xgeva Denosumab | 48 | 60 | Under 11 | $145K |
| Warfarin Sodium Generic | 43 | 92 | Under 11 | $342 |
| Anastrozole Generic | 43 | 79 | Under 11 | $438 |
| Lupron Depot Leuprolide Acetate | 34 | 105 | 12 | $187K |
| Somatuline Depot Lanreotide Acetate | 28 | 28 | Under 11 | $250K |
| Abiraterone Acetate Generic | 26 | 26 | Under 11 | $103K |
| Doptelet Avatrombopag Maleate | 23 | 23 | Under 11 | $289K |
| Jakafi Ruxolitinib Phosphate | 22 | 22 | Under 11 | $337K |
| Lenalidomide Generic | 21 | 21 | Under 11 | $272K |
| Procrit Epoetin Alfa | 20 | 20 | Under 11 | $78K |
Brand drugs: 768 claims; generic drugs: 490 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jin Guo $79.61 ($79.61 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $66.05.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.